HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Update on bazedoxifene: a novel selective estrogen receptor modulator.

Abstract
In the elderly population, osteoporosis is a significant clinical problem leading to disability and even death. Many patients remain untreated, despite effective therapies, because of patients' unwillingness to take current therapies or inability to tolerate the therapies. For this reason, ongoing research continues to search for more effective and tolerable osteoporosis agents. Bazedoxifene is a selective estrogen receptor modulator (SERM) currently in development for osteoporosis prevention and treatment. A new drug application (NDA) for postmenopausal osteoporosis prevention was recently submitted to the FDA. Preclinical and clinical studies with bazedoxifene demonstrate more tissue selectivity than other SERMs. In particular, bazedoxifene has minimal if any agonist activity in the uterus and is able to antagonize effects of estrogen on the uterus. Animal studies and early clinical studies suggest effects in the bone similar to other SERMs with prevention of postmenopausal bone loss. Until more data on efficacy and safety are published, however, its role in osteoporosis is unknown.
AuthorsDiane M Biskobing
JournalClinical interventions in aging (Clin Interv Aging) Vol. 2 Issue 3 Pg. 299-303 ( 2007) ISSN: 1176-9092 [Print] New Zealand
PMID18044180 (Publication Type: Journal Article, Review)
Chemical References
  • Bone Density Conservation Agents
  • Estrogens
  • Indoles
  • Selective Estrogen Receptor Modulators
  • bazedoxifene
Topics
  • Animals
  • Bone Density Conservation Agents (adverse effects, pharmacokinetics, therapeutic use)
  • Estrogens (metabolism)
  • Female
  • Humans
  • Indoles (adverse effects, pharmacokinetics, therapeutic use)
  • Osteoporosis (drug therapy, metabolism, prevention & control)
  • Osteoporosis, Postmenopausal (drug therapy, metabolism, prevention & control)
  • Selective Estrogen Receptor Modulators (adverse effects, pharmacokinetics, therapeutic use)
  • Treatment Outcome
  • Uterus (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: